posted on 2020-10-16, 21:55authored byAda AdminAda Admin, Charles-Henri Malbert, Alain Chauvin, Michael Horowitz, Karen L Jones
The glucose portal sensor informs the brain of changes
in glucose inflow via vagal afferents that require an activated GLP-1 receptor
(GLP-1r). The GLP-1 system is known to be impaired in insulin-resistant
conditions and we sought to understand the consequences of GLP-1 resistance on
glucose portal signaling. GLP-1-dependent portal glucose signaling was identified,
in vivo, using a novel 68Ga labeled GLP-1r positron-emitting probe that supplied
a quantitative in situ tridimensional representation of the portal sensor with
specific reference to the receptor density expressed in binding potential
units. It also served as a map for single-neuron electrophysiology driven by an
image-based abdominal navigation. We determined that, in insulin-resistant
animals, portal vagal afferents failed to inhibit their spiking activity during
glucose infusion, a GLP-1r-dependent function. This reflected a reduction in portal
GLP-1r binding potential, particularly between the splenic vein and the
entrance of the liver. We propose that insulin-resistance, through a reduction
in GLP-1r density, leads to functional portal desensitization with a consequent
suppression of vagal sensitivity to portal glucose.
Funding
The study was conducted within the Aniscan Imaging Center (Aniscan, INRA), which is supported by BPIFrance within the Investments for the Future program. KLJ’s salary is supported by The University of Adelaide William T Southcott Research Fellowship.